Name | debrisoquin |
---|---|
Synonyms |
3,4-Dihydroisoquinoline-2(1H)-carboxiMidaMide
EINECS 214-470-1 3,4-Dihydro-2(1H)-isochinolin-carboxamidin 3,4-dihydro-1H-isoquinoline-2-carboximidic acid amide 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide Debrisoquin Debrisochin 1,2,3,4-Tetrahydroisochinolin-N-carboxamidin 3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXAMIDINE Isocaramidine 3,4-Dihydro-2(1H)-isoquinolinecarbimidamide 3,4-dihydro-1H-isoquinoline-2-carboximidamide |
Description | Debrisoquin (Isocaramidine) is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner, with an IC50 of 22μM. Debrisoquin can be used for antiviral research[1]. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
References |
Density | 1.24g/cm3 |
---|---|
Boiling Point | 309.8ºC at 760mmHg |
Molecular Formula | C10H13N3 |
Molecular Weight | 175.23 |
Flash Point | 141.1ºC |
Exact Mass | 175.11100 |
PSA | 53.11000 |
LogP | 1.67610 |
Vapour Pressure | 0.000626mmHg at 25°C |
Index of Refraction | 1.649 |
HS Code | 2933499090 |
---|
~% 1131-64-2 |
Literature: Gruenewald, Sanja; Wahl, Bettina; Bittner, Florian; Hungeling, Helen; Kanzow, Stephanie; Kotthaus, Joscha; Schwering, Ulrike; Mendel, Ralf R.; Clement, Bernd Journal of Medicinal Chemistry, 2008 , vol. 51, # 24 p. 8173 - 8177 |
~% 1131-64-2 |
Literature: McNeilab, Inc. Patent: US4656291 A1, 1987 ; |
Precursor 2 | |
---|---|
DownStream 1 | |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |